Clinical Trial Update: A Feasibility Study of Topical Cannabinoids for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in Adults With Hormone Receptor-Positive Breast Cancer (CanAroma) [EARLY_Phase 1]

View source ↗

Summary

This is a completed early-phase feasibility study (CanAroma) evaluating topical cannabinoids for aromatase inhibitor-associated musculoskeletal syndrome in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aromatase Inhibitor-associated Musculoskeletal Syndrome
• Breast Cancer

Drugs mentioned

• Topical cannabinoids (CanAroma) (cannabinoids, topical)

Snippet

Sponsor: University of Minnesota | Conditions: Musculoskeletal Syndrome | EARLY_Phase 1 | Status: COMPLETED